Mohamed Sikkander Abdul Razak/LinkedIn
Apr 6, 2026, 10:03
Mohamed Sikkander Abdul Razak: Clinical Steps for Evaluating and Managing Heavy Menstrual Bleeding
Mohamed Sikkander Abdul Razak, Professor at GKM College of Engineering Technology, shared a post on LinkedIn:
“Clinical steps for evaluating and managing heavy menstrual bleeding (HMB):
1. Initial assessment:
- Detailed history (menstrual pattern, bleeding severity, iron deficiency, family history of bleeding disorders).
- Physical exam to rule out structural causes (e.g., fibroids).
2.Laboratory evaluation:
- Complete blood count (CBC) to check for anemia.
- Iron studies (serum ferritin, iron levels).
- Coagulation screening: PT, aPTT, von Willebrand factor (vWF) antigen/activity, platelet function tests.
3. Identify underlying hemostatic defect:
- Confirm vWD or platelet dysfunction (most common causes).
- Assess for factor deficiencies if indicated.
4.Management strategies:
Medical therapy:
- Hormonal treatments (combined oral contraceptives, levonorgestrel IUS) to regulate cycles and reduce bleeding.
- Antifibrinolytics (tranexamic acid) during menses to stabilize clots.
Hemostatic therapy:
- vWF concentrates or DDAVP for vWD.
- Platelet transfusions or specific factor replacement if needed.
Surgical options:
- Endometrial ablation or hysterectomy in refractory cases.
5. Pregnancy planning:
- Preconception counseling and hemostatic optimization to prevent miscarriage or postpartum hemorrhage.
- Specialist referral for individualized risk assessment.
6.Follow‑up:
- Monitor hemoglobin and iron levels.
- Re‑evaluate hemostatic workup if bleeding persists or complications arise.”

Find more posts featuring Mohamed Sikkander Abdul Razak on Hemostasis Today.
-
May 23, 2026, 16:55Rahul Bhargava: Ensure Equal Recognition of Clinical Haematologists in Blood Cancer Clinical Trials
-
May 23, 2026, 16:44Brian O Mahony: World Haemophilia Day Receives Global WHO Recognition
-
May 23, 2026, 16:44Yusuf Hameed: Gene Therapy Could Reduce Lifetime Treatment Burden in Hemophilia A
-
May 23, 2026, 16:43Chokri Ben Lamine: Pacritinib Is a Key JAK Inhibitor for Cytopenic Myelofibrosis
-
May 23, 2026, 16:42Bartosz Hudzik: Bleeding Risk Alone Should Not Determine Treatment Intensity
-
May 23, 2026, 16:42Shimels Tessema: Celebrating the WHA Resolution on Hemophilia and Other Bleeding Disorders
-
May 23, 2026, 16:38José Octavio Alva Bucio: Securing the Future of Plasma and Blood-Derived Medicines
-
May 23, 2026, 16:33Why Are We Dismantling What Powers Humanity and the Global Economy? – ASH
-
May 23, 2026, 16:24Marc Wittwer: A Practical Viscoelastic-Guided Algorithm for Trauma-Induced Coagulopathy in Clinical Workflow